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ABSTRACT
Objective: This study aimed to evaluate the efficacy of Centella asiatica leaf extract in maintaining calcium and phosphate levels in the bone for 
preventing osteoporosis in postmenopausal women.
Methods: The obtained C. asiatica leaf extract was administered to ovariectomized rats at the doses of 60, 120, and 180 mg/kg body weight (BW) 
for 30 days. Subsequently, the rats were euthanized by ether overdose, and bone calcium and phosphate levels were determined by the wet ashing 
technique and spectrophotometry.
Results: The results showed no significant differences in the bone calcium and phosphate levels among rats administered with different doses of 
C. asiatica leaf extract.
Conclusion: Our results indicate that C. asiatica leaf extract cannot be used as a source of phytoestrogens to maintain calcium and phosphate levels 
in the bones.
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INTRODUCTION
Osteoporosis is a chronic and progressive disease characterized by low 
bone mass, bone microstructure disorder, and decreased bone strength that 
causes brittleness and susceptibility to bone fracture [1]. It is associated 
with old age and has become a major health problem worldwide, including 
in developed countries, especially in postmenopausal women [2].
Bone remodeling is a process that maintains bone health by removing 
old bone cells and consistently replacing them with new ones. During 
menopause, bone resorption increases and causes an imbalance 
resulting in skeletal abnormalities, which increase the risk of 
fractures [2]. Decreased estrogen levels increase serum cytokine levels 
that lead to osteoclast formation and reactions in the trabecular bone, 
resulting in bone resorption [3].
Two types of cytokines are produced by bone marrow stromal cells 
and osteoblasts that are essential in osteoclastogenesis induced by 
macrophage colony-stimulating factor and receptor activator of nuclear 
factor kappa B ligand (RANKL), which are members of the tumor 
necrosis factor (TNF) superfamily. RANKL is expressed by mononuclear 
osteoclast precursors that play a role in osteoclast formation, whereas 
osteoprotegerin (OPG) is produced by stromal and osteoblast cells 
and is a natural inhibitor of RANKL and, therefore, antagonistic to the 
osteoclastogenic activity of RANKL [4].
Estrogen works by activating the Fas ligand that binds to estrogen 
receptors on the target cell [5]. Estrogen affects skeletal and 
extracellular activities. Skeletal activity can be direct and indirect. Direct 
skeletal activity is associated with estrogen receptors in osteoblasts 
and osteoclasts, whereas indirect activity is associated with estrogen 
receptors in other cells including stromal cells that regulate OPG and 
immune cells that affect bone homeostasis [4].
Estrogen deficiency in postmenopausal women results in increased 
RANKL expression in bone marrow cells, which increase osteoclast 
formation, leading to increased bone resorption. In addition, when 
estrogen is deficient, the stimulation of OPG formation in osteoblasts 
that create an antiresorptive effect on bone ceases [6].
Extracellular activity in estrogen deficiency increases calcium excretion 
in the kidneys and decreases calcium absorption in the intestines. 
Estrogen deficiency also causes increased parathyroid hormone levels 
as a compensation for the loss of calcium in the body. In addition, it 
is known that the increased production of various inflammatory 
cytokines and mediators, such as interleukin (IL)-1, IL-6, TNF-α, and 
prostaglandin E2, affects the pathogenesis of osteoporosis because it 
increases RANKL expression. Estrogen deficiency also affects cytokine 
function in the immune system. In addition, our study results showed 
that estrogen deficiency affects the activation of T-cells, which are also 
involved in the pathogenesis of osteoporosis [4].
Hormone replacement therapy is the only treatment that shows 
concrete results in terms of preventing the loss of bone mass density 
and reducing the risk of fracture in osteoporosis patients [2]. However, 
further, research on the long-term effects of hormone replacement 
therapy revealed that hormone therapy increases the risk of breast 
cancer, heart disease, thrombosis, and stroke. Therefore, this therapy 
has been discontinued because the risks exceed the benefits [7].
The word phytoestrogen is derived from “phyto” meaning plant 
because they are found in plants, and “estrogen,” due to their ability 
to function like naturally produced estrogen in the human body [8]. 
These compounds can bind to estrogen receptors in the body and can 
exhibit estrogen-like effects on the target tissues; therefore, they can 
be used as a substitute for estrogen in postmenopausal women in the 
form of a dietary supplement. Four types of compounds belong to this 
class of phytoestrogens, namely isoflavonoids, flavonoids, stilbenes, 
and lignans [8,9].
Centella asiatica (also known as gotu kola and Hydrocotyle asiatica) is an 
herb with kidney-shaped leaves found in India, Sri Lanka, Madagascar, 
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South Africa, Australia, China, and Japan [10]. It is used as a traditional 
medicine to treat various diseases [11]. Its pythritic leaves contain 
terpenoids, flavonoids, olive oil, and amino acids. Flavonoids found in 
C. asiatica include quercetin, kaempferol, catechin, rutin, naringin [6], 
apigenin, luteolin [12], castilliferol, and castillicetin [13]. It is known 
that several flavonoids found in C. asiatica are phytoestrogens that are 
beneficial for the bone health [14].
Quercetin and kaempferol are flavonols and phytoestrogens that can 
increase estrogen-like activity at certain doses [14,15]. In vitro quercetin 
and kaempferol not only inhibit bone resorption but also directly 
induce osteoclast apoptosis at certain doses. However, the mechanism 
underlying the induction of osteoclast apoptosis is difficult to uncover 
because at lower doses, these flavonoids, especially kaempferol, can 
even act as pro-oxidants. Several studies involving ovariectomized 
rats have also reported a significant decrease in bone resorption after 
quercetin administration [16].
Meanwhile, studies investigating estrogen deficiency in mice have shown 
that catechins increase osteoblast activity [17]. Catechins can suppress 
bone resorption and may be used as for treating osteoporosis [18]. Rutin 
may prevent osteopenia in ovariectomized rats [19], and certain doses 
of naringin can stimulate osteogenic activity in the line of osteoblasts 
and bone mesenchymal stem cells. Naringin has recently been shown to 
suppress the osteoclastogenic activity associated with IL-1 [20].
Apigenin has antioxidant, antitumor, and anti-inflammatory properties 
and inhibits the production of inflammatory mediators such as IL-6, 
TNF-α, and IL-8 [21]. The flavonoid luteolin is an important antioxidant, 
a free radical antagonist, an anti-inflammatory agent, and an immune 
system modulator. Research has shown that luteolin may inhibit TNF-α 
formation [22].
Building on the previous studies on the properties of compounds 
found in C. asiatica, the present study aimed to evaluate the efficacy 
of C. asiatica leaf extract in maintaining calcium and phosphate levels 
in the bone for preventing osteoporosis in postmenopausal women, as 
well as to determine the optimal dose.
METHODS
The study protocol had been approved by the Dental Research 
Ethics Committee, Faculty of Dentistry, Universitas Indonesia. In the 
experimental laboratory study, 30 rats were equally divided (five rats 
each) into the following six test groups: Sham, control (−), control 
(+), and treatment with C. asiatica leaf extract at doses of 60, 120, and 
180 mg/kg BW. All rats (except sham) were ovariectomized and treated 
for 30 days. Sham and control (−) rats were given distilled water, 
whereas control (+) rats were given Vitamin E.
C. asiatica leaf extract was obtained by drying, simplicia, immersion 
in alcohol, filtration, and evaporation to produce a thick extract. The 
extract was then dissolved in distilled water and administered to the 
rats daily through a feeding tube at the prescribed dose. Vitamin E 
was dissolved in vegetable oil and administered to control (+) animals 
through a feeding tube at a dose of 60 mg/kg BW.
On day 31, all rats were euthanized by ether overdose, and their 
thighs were removed and cleansed to obtain the femur and dry tibia. 
Calcium levels in the left femur and phosphate levels in the right 
femur were determined by the wet destruction technique followed by 
spectrophotometric analysis.
Calcium and phosphate level test results were analyzed by the 
Shapiro–Wilk normality test. Normally distributed data on calcium 
levels were then tested by one-way analysis of variance (ANOVA) 
and the Pearson correlation test. Data on phosphate levels were not 
normally distributed and were, therefore, tested by the non-parametric 
Kruskal–Wallis test and the Spearman correlation test. A significance 
level of 0.05 (p=0.05) and a confidence level of 95% (α=0.05) were 
considered in the statistical tests.
RESULTS
The measured calcium and phosphate levels in each group are presented 
in Figs. 1 and 2, respectively. One-way ANOVA revealed no significant 
difference in calcium levels among the treatment groups. The Pearson 
correlation test demonstrated a very weak and insignificant increase 
in calcium levels in the treatment groups compared with that in the 
Fig. 1: Mean femur bone calcium levels
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other groups. The Kruskal–Wallis test revealed no significant difference 
in phosphate levels among the treatment groups. The Spearman test 
detected an insignificant increase in phosphate levels in the treatment 
groups compared with that in the other groups.
DISCUSSION
Our results demonstrated no significant difference in the calcium and 
phosphate levels among the treatment groups. Although the correlation 
test showed a very weak correlation between the dose of C. asiatica leaf 
extract and calcium levels and a stronger correlation between the dose 
of C. asiatica leaf extract and phosphate levels, both correlations were 
insignificant. This is contradictory to the previous studies arguing that 
phytoestrogens may prevent bone resorption [9].
Several factors may explain why the results of this study are not in 
accordance with the findings of the previous studies: The mechanism of 
dose-dependent phytoestrogens, time required for osteoclasts to break 
the mineral crystals in bone, high bone mass, uncontrolled feeding of 
mice, and inaccuracy factors in the calculations.
Each phytoestrogen has specific active constituents that exert their 
function at different doses [23]. At certain doses, some phytoestrogens, 
such as kaempferol and quercetin, may function as pro-oxidant agents, 
causing oxidative stress that can increase osteoclast activity resulting in 
bone resorption [16]. Many studies have been conducted with the aim 
of identify the working dose of phytoestrogens, which have not yet been 
determined due to their complex actions [23].
C. asiatica contains unknown concentrations of several types of the 
phytoestrogens. In this study, the doses present in C. asiatica leaf 
extract may not have provided the desired effect. It is also possible that 
these individual phytoestrogens exert their function at different doses; 
therefore, the bone calcium and phosphate levels of ovariectomized 
rats were not significantly different from those of rats that were not 
administered C. asiatica extract. In addition, because of dose-dependent 
action of phytoestrogens, the different concentrations of C. asiatica 
extract might have failed to have affect bone calcium and phosphate 
levels.
Osteoclasts complete bone resorption in approximately 3 weeks [24]. 
In this study, the treatment time from ovariectomy to euthanasia was 
30 days, so bone mass changes were less visible. Moreover, the femur 
bone consists mainly of cortical bone that is slower to resorb than the 
trabecular bone [6,25]. Studies have shown that a significant increase 
in the femur mass attributed to catechins lasted for 3 months [17]. 
Our study period was not sufficient to show differences in calcium and 
phosphate levels in the rat femur bone.
One of the important factors in maintaining bone density is the 
iliac crest bone mass [26], which is influenced by race, age, gender, 
genetics, physical activity, and nutrient intake, especially that of 
calcium and Vitamin D [27]. Several factors that could affect this bone 
mass were not controlled in this study, such as physical activity and 
nutrient intake. The rats were left free in the cage, and each rat had a 
different level of activity. The amount of food intake of the rats was not 
controlled either, so the nutrient intake of each rat would also have 
been different depending on their appetite. Therefore, the highest 
bone mass of any uncontrolled rat would have affected the bone 
calcium and phosphate density, resulting in insignificant research 
results.
Natural products offer a rich source of structurally diverse substances 
with a wide range of biological activities, which could be useful 
for the development of alternative or adjunctive for osteoporosis 
therapies [28]. The market for anti-aging products is also growing 
gradually, and customers are aware of active principles in the 
cosmetics [29]. C. asiatica as natural product also can be an alternative 
treatment for osteoporosis in aging women.
CONCLUSION
Based on the results of this study, it can be concluded that C. asiatica 
leaf extract as a source of phytoestrogens could not help to maintain 
calcium and phosphate levels in the bones of ovariectomized rats. In 
addition, no difference was found among different concentrations of 
C.  asiatica leaf extract in terms of their effects on the bone calcium and 
phosphate content in the ovariectomized rats.
Fig. 2: Mean femur bone phosphate levels
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